CDC Deputy Director Dr. Jennifer Shuford Resigns

Dr. Jennifer Shuford has resigned from her position as deputy director and chief medical officer of the Centers for Disease Control and Prevention. She stepped down four months after President Trump appointed her to the role, a move intended to stabilize the agency. Shuford cited a desire to spend more time with family as her primary reason for leaving, though the resignation arrives at a moment of intense scrutiny for the CDC.

Dr. Demetre Daskalakis, who resigned as the CDC’s top immunization official last year, said he was not surprised by the news. Daskalakis currently serves as chief medical officer for Callen-Lorde in New York City. He noted that he had worked with Shuford when he headed the National Center for Immunization and Respiratory Diseases and she served as the state health official in Texas. Daskalakis described her as an excellent infectious disease doctor and a strong public health leader, suggesting he was more surprised that she joined the CDC under the current conditions.

Daskalakis criticized the current composition of the CDC director's office. He stated that while the current director, Dr. Erica Schwartz, holds qualifications, the office is now dominated by political operatives rather than career scientists. Daskalakis argued that Shuford was the last remaining official in that space with strong public health credentials. He said he does not have faith in Schwartz’s ability to act as a fully realized public health professional, describing the agency as feeling like a hijacked plane.

The shift in leadership structure represents a major change from previous years. Daskalakis noted that the director's office previously contained one or two political appointees alongside career scientists. Today, he said, there are over 20 political appointees in that office, with very few or no career scientists. He pointed to the cryptosporidium outbreak earlier this year as an example of the agency's new silence, noting that the CDC did not communicate much information to the public during that event.

Daskalakis compared the current communication style to his time at the agency. During outbreaks like measles and bird flu, the CDC held press availabilities almost every week to provide transparency. He stated that this frequent communication is no longer happening, leading to a lack of the science-based messaging the public expects. He suggested that the silence is strategic, making it easier for internal forces within the Department of Health and Human Services to reshape the CDC.

The agency has lost approximately 2,000 staff members since 2025. Daskalakis attributed the reduced public presence to both political reasons and these staff cuts. He warned that without a trusted public health voice, narratives about health challenges can spiral out of control. This lack of an official anchor confuses both public health officials and the general public during emergencies such as the current measles outbreak in the United States and the Ebola outbreak in Africa.

State and local governments are also feeling the impact. Daskalakis observed that these jurisdictions are forming regional organizations to share resources and expertise because they must fend for themselves. He noted that not every state has the same level of funding for public health. Consequently, well-resourced states can communicate effectively, while others with fewer resources struggle to find trustworthy sources of information as CDC messaging wanes.

The CDC has been contacted for comment regarding Shuford's resignation and the agency's current direction. As of the time of reporting, the agency had not responded. The departure of Shuford leaves the CDC without its chief medical officer as it manages ongoing domestic and international health threats.